Q1 2024 Holdings
Filed 2024-05-15 | 99 holdings | $960.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $82.0M | 2,254,797 | 8.5% |
| Evolus Inc(EOLS) | COM | 30052C107 | $58.1M | 4,147,399 | 6.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $48.9M | 4,125,345 | 5.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $30.0M | 1,330,879 | 3.1% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $29.8M | 1,187,107 | 3.1% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $28.0M | 2,750,000 | 2.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $26.4M | 405,600 | 2.7% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $24.5M | 700,000 | 2.5% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $21.0M | 27,000 | 2.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $20.5M | 300,000 | 2.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $20.4M | 700,000 | 2.1% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $19.3M | 1,619,412 | 2.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $17.8M | 660,000 | 1.9% |
| Immunome Inc(IMNM) | COM | 45257U108 | $17.8M | 720,000 | 1.9% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $17.7M | 1,047,275 | 1.8% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $17.1M | 3,100,000 | 1.8% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $16.5M | 4,076,741 | 1.7% |
| Elevation Oncology Inc | COM | 28623U101 | $15.7M | 3,060,000 | 1.6% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $15.2M | 2,230,000 | 1.6% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $15.1M | 6,407,400 | 1.6% |
| Morphosys AG | SPONSORED ADS | 617760202 | $14.5M | 800,705 | 1.5% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $14.1M | 6,450,000 | 1.5% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $12.9M | 3,551,864 | 1.3% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $12.9M | 300,000 | 1.3% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $12.2M | 547,616 | 1.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $12.1M | 692,925 | 1.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $11.6M | 1,100,000 | 1.2% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $10.4M | 466,809 | 1.1% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $10.4M | 150,000 | 1.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $10.4M | 150,000 | 1.1% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $10.3M | 2,050,000 | 1.1% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $10.2M | 150,000 | 1.1% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $9.9M | 500,000 | 1.0% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $9.7M | 571,138 | 1.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $9.6M | 518,900 | 1.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $9.4M | 281,200 | 1.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $9.4M | 600,000 | 1.0% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $9.0M | 10,000 | 0.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $8.2M | 100,000 | 0.9% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $8.1M | 1,603,200 | 0.8% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $8.0M | 589,569 | 0.8% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $7.9M | 264,692 | 0.8% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $7.9M | 116,500 | 0.8% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.7M | 140,000 | 0.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.4M | 180,000 | 0.8% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $7.4M | 500,000 | 0.8% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $7.2M | 1,751,654 | 0.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.0M | 100,000 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $6.6M | 100,000 | 0.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $6.5M | 150,000 | 0.7% |